OraLiva awarded $1.9M National Institute of Dental and Craniofacial Research (NIDCR at NIH) Direct to Phase II SBIR grant for AI-linked cytomics-on-a-chip Read More
Provider Login

OraLiva for Specialists

Bring Pathology-Level Insight to Every Exam

Designed for Referral
Precision. Built for Real
World Practice.

With fast turnaround, AI-powered reporting, and no disruption to your process, OraLiva fits seamlessly into follow-up visits and specialty assessments.
  • No scalpel or anesthesia.
  • Comfortable for patients, collected in minutes
  • Risk-stratified reports that support timely clinical decisions

OraLiva in Everyday Practice

OraLiva makes oral cancer screening straightforward for general dentists. Below is how it fits into a typical patient visit, from sample collection to secure digital reporting

1

In-Visit Sample
Collection

During an exam or consult, OraLiva’s soft brush collects epithelial cells from a referred lesion. The process is quick, comfortable for the patient, and within a standard specialty appointment

2

AI-Guided Cytology Analysis

Using a dataset of over 13 million cells, the AI assesses morphological features and returns a structured risk score with 97% accuracy for dysplasia and early malignancy.

3

Rapid, Actionable Reporting

Specialists receive a clear diagnostic report through a secure portal with a diagnostic score and pathological interpretation. This supports confident triage: close monitoring or intervention.

Why Specialists Choose
OraLiva

Specialists choose OraLiva because it brings clarity to referral-based care without adding complexity.
The procedure is quick, well-tolerated by patients, and easy to incorporate into follow-up visits. Results are delivered fast, risk-scored for triage, and supported by peer-reviewed validation. It’s a precise, efficient way to evaluate lesions and reduce unnecessary procedures.
  • Objective Reporting
    Structured risk scores to support clear decisions
  • Minimally Invasive Collection
    Peer-reviewed and NIH-supported
  • High Diagnostic Confidence
    AI analysis supported by peer-reviewed trials
  • Triage Efficiency
    Identify high-risk cases sooner,
  • Fewer Unnecessary Biopsies
    Avoid invasive procedures for benign lesions
  • Fast Turnaround
    Results delivered digitally in 1–2 weeks

Get Started Today

Interested in using OraLiva in your practice? Complete the form and our team will reach out with details..

Stay Informed on the Future of Oral Cancer Detection

Join the OraLiva wait list for product launch news and insights designed to support your team and improve early cancer detection in everyday care.

Get exclusive early access.

Join OraLiva's Waitlist